SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2013 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 14th, 2013 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 8, 2013, between Vermillion, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
STOCKHOLDERS AGREEMENTStockholders Agreement • May 14th, 2013 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 14th, 2013 Company Industry JurisdictionThis STOCKHOLDERS AGREEMENT (the “Agreement”) is made as of May 13, 2013 by and among Vermillion, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Jack W. Schuler (“Schuler” and together with Oracle, the “Principal Purchasers”) and the other purchasers named in the Purchase Agreement (as defined below) (collectively, the “Purchasers”).